De Cock Lore, Palubeckaitė Ieva, Bersani Francesca, Faehling Tobias, Pasquali Sandro, Umbaugh Sam, Meister Michael Torsten, Danks Molly R, Manasterski Piotr, Miallot Richard, Krumbholz Manuela, Roohani Siyer, Heymann Dominique, Cidre-Aranaz Florencia, Wozniak Agnieszka, Schöffski Patrick, Bovée Judith V M G, Merlini Alessandra, Venneker Sanne
Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
Neoplasia. 2025 Jul;65:101171. doi: 10.1016/j.neo.2025.101171. Epub 2025 May 3.
Sarcomas are a large family of rare and heterogeneous mesenchymal tumors, which respond poorly to available systemic treatments. Translation of preclinical findings into clinical applications has been slow, limiting improvements in patients' outcomes and ultimately highlighting the need for a better understanding of sarcoma biology to develop more effective, subtype-specific therapies. To this end, reliable preclinical models are crucial, but the development of 3D in vitro sarcoma models has been lagging behind that of epithelial cancers. This is primarily due to the rarity and heterogeneity of sarcomas, and lack of widespread knowledge regarding the optimal growth conditions of these in vitro models. In this review, we provide an overview of currently available sarcoma tumoroid models, together with guidelines and suggestions for model development and characterization, on behalf of the FORTRESS (Forum For Translational Research in Sarcomas) international research working group on 3D sarcoma models.
肉瘤是一大类罕见且异质性的间充质肿瘤,对现有的全身治疗反应不佳。临床前研究结果转化为临床应用的速度一直很缓慢,限制了患者治疗效果的改善,并最终凸显了更好地了解肉瘤生物学以开发更有效、亚型特异性疗法的必要性。为此,可靠的临床前模型至关重要,但三维体外肉瘤模型的开发一直落后于上皮性癌。这主要是由于肉瘤的罕见性和异质性,以及缺乏关于这些体外模型最佳生长条件的广泛知识。在本综述中,我们代表肉瘤转化研究论坛(FORTRESS)国际三维肉瘤模型研究工作组,概述了目前可用的肉瘤类肿瘤模型,以及模型开发和表征的指南与建议。